Medical decisional capacity among children with HIV

Tiffany Chenneville1, Kimberly Sibille, Jorge Lujan-Zilbermann

  • 1Department of Psychology, University of South Florida St. Petersburg, 33705, USA. chennevi@mail.usf.edu

AIDS Care
|August 6, 2010
PubMed

Insights

Children with HIV can make healthcare decisions, demonstrating decisional capacity (DC). Despite lower intellectual and adaptive functioning, their ability to understand and participate in medical care remains intact.

Area of Science:

  • Pediatric Health
  • HIV/AIDS Research
  • Clinical Psychology

Background:

  • Decisional capacity (DC) is crucial for children's healthcare involvement, especially for those with chronic conditions like HIV.
  • Understanding factors influencing DC in pediatric HIV is vital for effective disease management and patient-centered care.

Purpose of the Study:

  • To assess the relationship between decisional capacity (DC), developmental stage, intellectual ability, and social-emotional functioning in children with and without HIV.
  • To determine if children living with HIV exhibit differences in DC compared to their HIV-negative peers.

Main Methods:

  • Cross-sectional study involving 50 children (with and without HIV infection).
  • Evaluated decisional capacity, developmental stage, intellectual ability, and social-emotional functioning using standardized measures.
  • Statistical analysis to explore correlations and group differences.

Main Results:

  • A positive correlation was observed between developmental stage and the understanding component of DC.
  • Children with HIV showed significantly lower scores in intellectual and adaptive functioning.
  • No significant difference in overall decisional capacity (DC) was found between children with and without HIV.

Conclusions:

  • Children living with HIV possess the necessary decisional capacity to participate meaningfully in their healthcare decisions.
  • Lower intellectual and adaptive functioning in pediatric HIV does not impede their ability to make informed health choices.
  • Findings support the inclusion of children with HIV in shared medical decision-making processes.

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Ethical Dilemmas I01:17

Ethical Dilemmas I

Ethical dilemmas in nursing are of utmost importance, as they often arise from the tension between adhering to core ethical principles and the practical realities of healthcare delivery. These dilemmas require nurses to navigate complex situations where competing ethical considerations pull them in different directions.
Let us explore some examples to understand the potentially complex moral decisions nurses face.
Take the case of caring for minors, particularly in areas related to reproductive...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...